Fulvestrant-induced expression of erbB3 and erbB4 sensitizes ER-positive breast cancer cells to heregulins

被引：1
|
作者：
Hutcheson, I. R. [1 ]
Goddard, L. [1 ]
Gee, J. M. W. [1 ]
Barrow, D. [1 ]
Nicholson, R. I. [1 ]
机构：
[1] Cardiff Univ, Cardiff, S Glam, Wales
来源：
BREAST CANCER RESEARCH | 2010年 / 12卷
关键词：
T47D Cell; Fulvestrant; erbB Receptor; Related Family Member; Induce Protein Expression;
D O I：
10.1186/bcr2510
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S5 / S6
页数：2
相关论文
共 50 条
  • [31] ErbB4 negatively regulates vasculogenic mimicry of human breast cancer cells
    Kawahara, Ryota
    Simizu, Siro
    [J]. CANCER SCIENCE, 2022, 113 : 1005 - 1005
  • [32] Tetraspanin CD151 impairs heterodimerization of ErbB2/ErbB3 in breast cancer cells
    Mieszkowska, Magdalena
    Piasecka, Dominika
    Potemski, Piotr
    Debska-Szmich, Sylwia
    Rychlowski, Michal
    Kordek, Radzislaw
    Sadej, Rafal
    Romanska, Hanna M.
    [J]. TRANSLATIONAL RESEARCH, 2019, 207 : 44 - 55
  • [33] Aptamer-protamine-siRNA nanoparticles in targeted therapy of ErbB3 positive breast cancer cells
    Xu, Xiangshang
    Li, Li
    Li, Xiaolan
    Tao, Deding
    Zhang, Peng
    Gong, Jianping
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2020, 590
  • [34] Differential Distribution of erbB Receptors in Human Glioblastoma Multiforme: Expression of erbB3 in CD133-Positive Putative Cancer Stem Cells
    Duhem-Tonnelle, Veronique
    Bieche, Ivan
    Vacher, Sophie
    Loyens, Anne
    Maurage, Claude-Alain
    Collier, Francis
    Baroncini, Marc
    Blond, Serge
    Prevot, Vincent
    Sharif, Ariane
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2010, 69 (06): : 606 - 622
  • [35] Receptor tyrosine kinase ERBB4 mediates acquired resistance to ERBB2 inhibitors in breast cancer cells
    Canfield, Kaleigh
    Li, Jiaqi
    Wilkins, Owen M.
    Morrison, Meghan M.
    Ung, Matthew
    Wells, Wendy
    Williams, Charlotte R.
    Liby, Karen T.
    Vullhorst, Detlef
    Buonanno, Andres
    Hu, Huizhong
    Schiff, Rachel
    Cook, Rebecca S.
    Kurokawa, Manabu
    [J]. CELL CYCLE, 2015, 14 (04) : 648 - 655
  • [36] Changes in ErbB2 (her-2/neu), ErbB3, and ErbB4 during growth, differentiation, and apoptosis of normal rat mammary epithelial cells
    Darcy, KM
    Zangani, D
    Wohlhueter, AL
    Huang, RY
    Vaughan, MM
    Russell, JA
    Ip, MM
    [J]. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2000, 48 (01) : 63 - 80
  • [37] ErbB3 Expression Is Required for Maintenance of Normal and Transformed Luminal Breast Epithelial Cells
    Cook, R. S.
    Balko, J. M.
    Rinehart, C.
    Miller, T. W.
    Polyak, K.
    Prat, A.
    Perou, C. M.
    Arteaga, C. L.
    [J]. CANCER RESEARCH, 2011, 71
  • [38] ERBB3 mRNA expression in breast cancer (BC): A SOLTI biomarker discovery analysis
    Pascual, T.
    Oliveira, M.
    Ciruelos, E. M.
    Bellet Ezquerra, M.
    Saura, C.
    Gavila Gregori, J.
    Pernas Simon, S.
    Munoz, M.
    Vidal, M. J.
    Margeli Vila, M.
    Cejalvo, J. M.
    Gonzalez-Farre, B.
    Espinosa-Bravo, M.
    Ferrero-Cafiero, J. M.
    Villagrasa, P.
    Prat, A.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S15 - S16
  • [39] Decreased LRIG1 in fulvestrant-treated luminal breast cancer cells permits ErbB3 upregulation and increased growth
    M M Morrison
    M M Williams
    D B Vaught
    D Hicks
    J Lim
    C McKernan
    L Aurisicchio
    G Ciliberto
    C Simion
    C Sweeney
    R S Cook
    [J]. Oncogene, 2016, 35 : 1143 - 1152
  • [40] ERRF sensitizes ERBB2-positive breast cancer cells to lapatinib treatment likely by attenuating MCL1 and ERBB2 expression
    Qi, Leilei
    Zhang, Baotong
    Zhang, Shiying
    Ci, Xinpei
    Wu, Qiao
    Ma, Gui
    Luo, Ang
    Fu, Liya
    King, Jamie L.
    Nahta, Rita
    Dong, Jin-Tang
    [J]. ONCOTARGET, 2017, 8 (22) : 36054 - 36066
12345